Pulse Brain · Growing Health Evidence Index
Tier 4 — Narrative / commentaryIndustry / policy report

Mounjaro (2024)

Mounjaro

2024

All evidence

Summary

Pulse Check candidate — author/year captured from a claim that was Outside Catalogue. Claim: "GLP-1 RAs for weight management on NHS were approved in the UK in 2020 (Saxenda), followed by Wegovy (2023) and Mounjaro (2024); Saxenda was approved for private use in 2017." Context: … UK in 2020 (Saxenda), followed by Wegovy (2023) and Mounjaro (2024) – Saxenda was approved for private use in 2017. GLP-1 RAs for weight management on NHS wer …

Outcomes reported

Pulse Check candidate — author/year captured from a claim that was Outside Catalogue. Claim: "GLP-1 RAs for weight management on NHS were approved in the UK in 2020 (Saxenda), followed by Wegovy (2023) and Mounjaro (2024); Saxenda was approved for private use in 2017." Context: … UK in 2020 (Saxenda), followed by Wegovy (2023) and Mounjaro (2024) – Saxenda was approved for private use in 2017. GLP-1 RAs for weight management on NHS wer …

Theme
Farming systems, soils & land use
Subject
Other / interdisciplinary
Study type
Policy
Study design
Industry report
Source type
Industry/policy report
Status
Published
Geography
United Kingdom
System type
Other
Catalogue ID
IRmoskigyh-80bc88
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.